Krsnaa Diagnostics Limited (NSE:KRSNAA)
856.05
+1.65 (0.19%)
Jul 23, 2025, 3:29 PM IST
Krsnaa Diagnostics Revenue
In the fiscal year ending March 31, 2025, Krsnaa Diagnostics had annual revenue of 7.17B INR with 15.74% growth. Krsnaa Diagnostics had revenue of 1.86B in the quarter ending March 31, 2025, with 11.90% growth.
Revenue
7.17B
Revenue Growth
+15.74%
P/S Ratio
3.86
Revenue / Employee
n/a
Employees
3,700
Market Cap
27.72B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Glenmark Pharmaceuticals | 134.35B |
Krsnaa Diagnostics News
- 15 days ago - Krsnaa Diagnostics gets Rajasthan High Court nod, to proceed with NHM lab services contract - Business Upturn
- 3 months ago - Top stocks to buy today: Stock recommendations for April 23, 2025 - The Times of India
- 8 months ago - Lab stops blood collection at 400 BMC hosps over pending dues - The Times of India
- 9 months ago - Krsnaa Diagnostics shares surge nearly 6% as Q2 net sales reach ₹186.34 crore - Business Upturn
- 10 months ago - Stock in Focus: Krsnaa Diagnostics secures two major agreements in Ranchi - Business Upturn
- 10 months ago - Krsnaa Diagnostics to acquire 24% stake in start-up Apulki Healthcare - The Times of India
- 10 months ago - Krsnaa Diagnostics secures radiology services contract at Sadar Hospital, Ranchi - Business Upturn
- 10 months ago - Krsnaa Diagnostics acquires stake in India’s first PPP cancer and cardiac care hospitals - Business Upturn